[4146.354]] BACKGROUND: Sepsis is a major cause of morbidity and mortality in newborns. Recently, presepsin (soluble CD14subtype, sCD14-ST) has been shown to be beneficial as sepsis marker in adults. Nevertheless, few data are availablein newborns.OBJECTIVE: To determine: 1) the reference ranges for presepsin in healthy term newborns 2) the reference rangesfor presepsin in preterm newborns without clinical signs of sepsis 3) the diagnostic accuracy of presepsin as a markerof sepsis in newborns.DESIGN/METHODS: All infants admitted to our Unit during a 18-months period are enrolled into 3 groups: 1) healthyterm newborns 2) preterm newborns without clinical signs of sepsis 3) term and preterm newborns with clinical signsof sepsis. To measure presepsin, 100 microliters of blood are collected on day 3 of life in newborns of group 1 and 2and at the following times in newborns of group 3: at the onset of clinical signs of sepsis (T0), every 12 h for the next48 h (T1, T2, T3, T4), and at the end of antibiotic therapy (T5). C-reactive protein (CRP) is determined at the sametimes. Presepsin levels are determined using Pathfast® Immunoanalyzer (Mitsubishi Chemical Medience Corporation;Gepa Diagnostics).RESULTS: Until now, we enrolled 487 newborns in group 1 (mean GA 38.9 wks, mean BW 3211 g), 168 in group 2(mean GA 33.9 wks, mean BW 2052 g) and 42 in group 3 (mean GA 32.4 wks, mean BW 1811 g). Mean presepsinvalue was 650.2 pg/ml (SD 258.2; Median 603.5, Q1-Q3 468 – 794) in group 1 and 722.3 pg/ml (SD 339.4; Median636, Q1-Q3 506 – 862) in group 2. GA, gender, ethnicity, mode of delivery, SGA, twin, maternal fever, and stainedamniotic fluid did not affect presepsin levels. In group 3, mean presepsin value was 1087,5 pg/ml at T0 anddecreased over time to 743 pg/ml at T5. 14/42 neonates in group 3 had a positive blood culture, 26 had a negativeblood culture. Presepsin values were higher in infants with proven sepsis than in the others at T0, 1, 2, 3 and 4 (p <.01). CRP values were higher in infants with proven sepsis than in the others only from T2.CONCLUSIONS: Reference ranges for presepsin, determined for the first time in a large sample of healthy term andpreterm newborns, are much higher than in adults. Presepsin seems to be an accurate and early biomarker for thediagnosis of neonatal sepsis.

Presepsin (Soluble CD 14 Subtype) in Term and Preterm Newborns: Preliminary Reference Ranges and Usefulness in the Diagnosis of Sepsis / L. Pugni, C. Pietrasanta, M. Falbo, T. Todorovic, A. Ronchi, S. Perniciaro, M. Casartelli, C. Vener, S. Milani, F. Mosca. ((Intervento presentato al convegno Pediatric Academic Societies (PAS) Annual Meeting: April, 25th - 28th tenutosi a San Diego (CAL USA) nel 2015.

Presepsin (Soluble CD 14 Subtype) in Term and Preterm Newborns: Preliminary Reference Ranges and Usefulness in the Diagnosis of Sepsis

C. Pietrasanta
Secondo
;
T. Todorovic;S. Perniciaro;C. Vener;F. Mosca
2015

Abstract

[4146.354]] BACKGROUND: Sepsis is a major cause of morbidity and mortality in newborns. Recently, presepsin (soluble CD14subtype, sCD14-ST) has been shown to be beneficial as sepsis marker in adults. Nevertheless, few data are availablein newborns.OBJECTIVE: To determine: 1) the reference ranges for presepsin in healthy term newborns 2) the reference rangesfor presepsin in preterm newborns without clinical signs of sepsis 3) the diagnostic accuracy of presepsin as a markerof sepsis in newborns.DESIGN/METHODS: All infants admitted to our Unit during a 18-months period are enrolled into 3 groups: 1) healthyterm newborns 2) preterm newborns without clinical signs of sepsis 3) term and preterm newborns with clinical signsof sepsis. To measure presepsin, 100 microliters of blood are collected on day 3 of life in newborns of group 1 and 2and at the following times in newborns of group 3: at the onset of clinical signs of sepsis (T0), every 12 h for the next48 h (T1, T2, T3, T4), and at the end of antibiotic therapy (T5). C-reactive protein (CRP) is determined at the sametimes. Presepsin levels are determined using Pathfast® Immunoanalyzer (Mitsubishi Chemical Medience Corporation;Gepa Diagnostics).RESULTS: Until now, we enrolled 487 newborns in group 1 (mean GA 38.9 wks, mean BW 3211 g), 168 in group 2(mean GA 33.9 wks, mean BW 2052 g) and 42 in group 3 (mean GA 32.4 wks, mean BW 1811 g). Mean presepsinvalue was 650.2 pg/ml (SD 258.2; Median 603.5, Q1-Q3 468 – 794) in group 1 and 722.3 pg/ml (SD 339.4; Median636, Q1-Q3 506 – 862) in group 2. GA, gender, ethnicity, mode of delivery, SGA, twin, maternal fever, and stainedamniotic fluid did not affect presepsin levels. In group 3, mean presepsin value was 1087,5 pg/ml at T0 anddecreased over time to 743 pg/ml at T5. 14/42 neonates in group 3 had a positive blood culture, 26 had a negativeblood culture. Presepsin values were higher in infants with proven sepsis than in the others at T0, 1, 2, 3 and 4 (p <.01). CRP values were higher in infants with proven sepsis than in the others only from T2.CONCLUSIONS: Reference ranges for presepsin, determined for the first time in a large sample of healthy term andpreterm newborns, are much higher than in adults. Presepsin seems to be an accurate and early biomarker for thediagnosis of neonatal sepsis.
25-apr-2015
Settore MED/01 - Statistica Medica
Presepsin (Soluble CD 14 Subtype) in Term and Preterm Newborns: Preliminary Reference Ranges and Usefulness in the Diagnosis of Sepsis / L. Pugni, C. Pietrasanta, M. Falbo, T. Todorovic, A. Ronchi, S. Perniciaro, M. Casartelli, C. Vener, S. Milani, F. Mosca. ((Intervento presentato al convegno Pediatric Academic Societies (PAS) Annual Meeting: April, 25th - 28th tenutosi a San Diego (CAL USA) nel 2015.
Conference Object
File in questo prodotto:
File Dimensione Formato  
pas 2015 presepsin.pdf

accesso aperto

Tipologia: Altro
Dimensione 60.91 kB
Formato Adobe PDF
60.91 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/561152
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact